Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by Findingmoneyon Aug 13, 2020 8:32am
190 Views
Post# 31402119

RE:RE:Calls for FDA to speed up approval for at-home testing

RE:RE:Calls for FDA to speed up approval for at-home testingWhat is the point of FDA approval of kits that do not work towards truly identifying the problem? If they entertain multiple tests for labs that would create an even greater backlog of tests that they cannot keep up with now. If the accuracy of the new take home tests starts out with a poor percentage, imagine once the common person is allowed to administer the test, the accuracy would drop to even lower levels. I think the FDA is correct to STOP and take a snapshot of the madness where embellished claims are being made and not proven. The only way is to first have a test that can pass all of the criteria that is needed to combat this. Second, the coordination of testing results as quickly as possible can not come from multiple test methods with varying accuracy results and time result differences, no they must make sure that any tests passed work in conjunction with reporting the where and when so they can tie together what is happening, so again SONA is the only one that may truly rise to the occasion to meet all of the criteria. IMO      

<< Previous
Bullboard Posts
Next >>